Literature DB >> 16157976

Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer.

Keisuke Aoe1, Akio Hiraki, Tadashi Maeda, Hideki Katayama, Keiichi Fujiwara, Masahiro Tabata, Katsuyuki Kiura, Hiroshi Ueoka, Mitsune Tanimoto.   

Abstract

OBJECTIVES: Anemia is observed in various malignancies including lung cancer and is recently considered to be a poor prognostic indicator. We investigated whether there is a correlation between anemia, other clinicopathologic factors, and survival.
METHODS: We retrospectively examined the clinical records of 611 patients with lung cancer.
RESULTS: Of those, 298 (48.8%) patients had anemia at the time of their first visit to our hospital. There was a significant correlation between anemia and age (p=0.0006) or ECOG performance status (p=0.0002), however, there was no correlation of anemia with gender, histological type, clinical stage, or serum level of lactate dehydrogenase. Survival was significantly shorter in 298 patients with anemia (median survival time (MST): 7.5 months) compared with 313 patients without anemia (MST: 11.8 months, p<0.0001). Multivariate analysis of prognostic factors using the Cox proportional hazards model revealed that anemia appeared to be an independent prognostic indicator.
CONCLUSION: Anemia observed at the first presentation is an independent poor prognostic indicator in patients with lung cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157976     DOI: 10.2169/internalmedicine.44.800

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  14 in total

1.  Anemia and Functional Disability in Older Adults With Cancer.

Authors:  Cynthia Owusu; Harvey Jay Cohen; Tao Feng; William Tew; Supriya G Mohile; Heidi D Klepin; Cary P Gross; Ajeet Gajra; Stuart M Lichtman; Arti Hurria
Journal:  J Natl Compr Canc Netw       Date:  2015-10       Impact factor: 11.908

2.  The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy.

Authors:  Mark Vincent; George Dranitsaris; Sunil Verma; Cathy Lau; Pere Gascon; Simon Van Belle; Heinz Ludwig
Journal:  Support Care Cancer       Date:  2006-11-21       Impact factor: 3.603

3.  Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer.

Authors:  Yue-Hua Zhang; Yuquan Lu; Hong Lu; Meng-Wei Zhang; Yue-Min Zhou; Xiang-Lei Li; Pin Lv; Xiao-Yan Zhao
Journal:  Mol Clin Oncol       Date:  2018-05-16

4.  Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma.

Authors:  Seigo Minami; Yoshitaka Ogata; Shouichi Ihara; Suguru Yamamoto; Kiyoshi Komuta
Journal:  Lung Cancer (Auckl)       Date:  2016-08-24

Review 5.  Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis.

Authors:  Jiao Zhang; Yan-Hong Yao; Bao-Guo Li; Qing Yang; Peng-Yu Zhang; Hai-Tao Wang
Journal:  Sci Rep       Date:  2015-04-22       Impact factor: 4.379

6.  Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma.

Authors:  Yue-Hua Zhang; Yuquan Lu; Hong Lu; Meng-Wei Zhang; Yue-Min Zhou; Xiang-Lei Li
Journal:  Can Respir J       Date:  2018-05-15       Impact factor: 2.409

7.  Clinical significance of anemia as a prognostic factor in non-small cell lung cancer carcinoma with activating epidermal growth factor receptor mutations.

Authors:  Hye Seon Kang; Ah Young Shin; Chang Dong Yeo; Chan Kwon Park; Ju Sang Kim; Jin Woo Kim; Seung Joon Kim; Sang Haak Lee; Sung Kyoung Kim
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

8.  The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.

Authors:  Yaqi Huang; Siqi Wei; Nan Jiang; Lijuan Zhang; Siyuan Wang; Xiaona Cao; Yue Zhao; Peiguo Wang
Journal:  BMC Cancer       Date:  2018-12-10       Impact factor: 4.430

9.  The value of hemoglobin-to-red blood cell distribution width ratio (Hb/RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the diagnosis of nasopharyngeal cancer.

Authors:  Zhongyuan Lin; Xuan Zhang; Yu Luo; Yanyun Chen; Yulin Yuan
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

10.  Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.

Authors:  Joanna Szkandera; Armin Gerger; Bernadette Liegl-Atzwanger; Michael Stotz; Hellmut Samonigg; Ferdinand Ploner; Tatjana Stojakovic; Andreas Leithner; Martin Pichler
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.